title: Bradykinin is not involved in angiotensin converting enzyme modulation of ovarian steroidogenesis and prostaglandin production in frog Rana esculenta.
abstract: Angiotensin converting enzyme (ACE) was demonstrated to modulate the production of 17beta-estradiol, progesterone and prostaglandin E2 (PGE2) in frog ovary of Rana esculenta. However, the activity was not mediated by angiotensin II (Ang II). In an attempt to identify the peptide involved in the pathway modulated by ACE, bradykinin, another physiological substrate of ACE, was chosen and incubated in the presence of the membrane suspension purified from the frog ovary homogenate. The hydrolytic products were analysed by reverse-phase high-pressure liquid chromatography (HPLC) analysis and the results showed that bradykinin was metabolized by membrane suspension. The presence of the protease inhibitors in the incubation mixture indicated ACE and neutral endopeptidase as being responsible for the bradykinin hydrolysis. Frog ovary was incubated in vitro in the presence of bradykinin (10 microM), bradykinin receptor antagonist NPC 567 (1 mg mL-1), bradykinin fragment (1-7) (10 microM), ACE (2.5 mU mL-1), captopril (0.1 mM) and lisinopril (0.1 mM). The results showed no modulating activity by bradykinin on ovarian 17beta-estradiol and PGE2 production, thus demonstrating that it was not involved in the ACE-modulated pathway.
authors.affiliation: Department of Molecular, Cellular and Animal Biology, University of Camerino, Italy.
authors.forename: M
authors.initials: M
authors.lastname: Bramucci
authors.forename: A
authors.initials: A
authors.lastname: Miano
authors.forename: A
authors.initials: A
authors.lastname: Gobbetti
authors.forename: M
authors.initials: M
authors.lastname: Zerani
authors.forename: L
authors.initials: L
authors.lastname: Quassinti
authors.forename: E
authors.initials: E
authors.lastname: Maccari
authors.forename: O
authors.initials: O
authors.lastname: Murri
authors.forename: D
authors.initials: D
authors.lastname: Amici
mesh_terms: D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology; D000818:Animals; D001920:Bradykinin / Q000378:metabolism* / Q000494:pharmacology; D065168:Bradykinin Receptor Antagonists; D002457:Cell Extracts / Q000494:pharmacology; D002851:Chromatography, High Pressure Liquid; D015232:Dinoprostone / Q000096:biosynthesis; D004958:Estradiol / Q000096:biosynthesis; D005260:Female; D006868:Hydrolysis / Q000187:drug effects; D010053:Ovary / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D007703:Peptidyl-Dipeptidase A / Q000302:isolation & purification / Q000378:metabolism* / Q000494:pharmacology; D011453:Prostaglandins / Q000096:biosynthesis*; D011893:Rana esculenta / Q000378:metabolism*; D018002:Receptors, Bradykinin / Q000378:metabolism; D013997:Time Factors
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D065168:Bradykinin Receptor Antagonists; D002457:Cell Extracts; D011453:Prostaglandins; D018002:Receptors, Bradykinin; D004958:Estradiol; D007703:Peptidyl-Dipeptidase A; D015232:Dinoprostone; D001920:Bradykinin